CVKD NASDAQ
Cadrenal Therapeutics, Inc. Common Stock
1W: -16.1%
1M: -27.5%
3M: -71.3%
YTD: -86.8%
1Y: -93.1%
3Y: -90.4%
$0.94
-0.03 (-3.07%)
Weekly Expected Move ±13.1%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
ESG Scores — CVKD
Company vs Sector Average
Historical ESG Trend
View All ESG Filings (15)
| Date | Form | Environmental | Social | Governance | ESG Score | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | 10-Q | 50.0 | 63.6 | 60.5 | 58.0 | SEC ↗ |
| 2026-03-31 | 10-Q | 54.2 | 63.7 | 59.6 | 59.2 | SEC ↗ |
| 2025-12-31 | 10-K | 55.8 | 65.4 | 61.3 | 60.8 | SEC ↗ |
| 2025-09-30 | 10-Q | 54.6 | 70.6 | 67.0 | 64.1 | SEC ↗ |
| 2025-06-30 | 10-Q | 67.2 | 69.6 | 67.3 | 68.0 | SEC ↗ |
| 2025-03-31 | 10-Q | 67.2 | 68.1 | 66.0 | 67.1 | SEC ↗ |
| 2024-12-31 | 10-K | 58.2 | 65.3 | 63.3 | 62.3 | SEC ↗ |
| 2024-09-30 | 10-Q | 63.3 | 60.4 | 63.8 | 62.5 | SEC ↗ |
| 2024-06-30 | 10-Q | 69.3 | 60.7 | 63.1 | 64.4 | SEC ↗ |
| 2024-03-31 | 10-Q | 53.3 | 60.4 | 64.9 | 59.5 | SEC ↗ |
| 2023-12-31 | 10-K | 56.0 | 64.3 | 62.6 | 61.0 | SEC ↗ |
| 2023-09-30 | 10-Q | 53.3 | 64.8 | 66.8 | 61.6 | SEC ↗ |
| 2023-06-30 | 10-Q | 53.2 | 61.8 | 71.0 | 62.0 | SEC ↗ |
| 2023-03-31 | 10-Q | 53.2 | 62.5 | 71.7 | 62.5 | SEC ↗ |
| 2022-12-31 | 10-K | 64.3 | 67.2 | 65.6 | 65.7 | SEC ↗ |